IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1309 
     Home | Feedback | Reader Login
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE here  
     Search
     Current Issue
     Submit Article 
     My Preferences 
     Dermatology crossword 

 


Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2004| July-August  | Volume 70 | Issue 4  
 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEW ARTICLE
Narrow band UVB phototherapy in dermatology
Sunil Dogra, Amrinder Jit Kanwar
July-August 2004, 70(4):205-209
PMID:17642615
  49,092 1,796 1
MEDICAL EDUCATION
Dermatology training and career options in the U.K. for Indian graduates
Shernaz Walton, Andrew Finlay
July-August 2004, 70(4):256-259
PMID:17642632
  39,623 429 -
GET SET FOR THE NET
Websites on hair transplantation
Vinay Gopalani
July-August 2004, 70(4):260-261
PMID:17642633
  28,512 367 -
RESIDENTS«SQ» PAGE
Cutaneous signs in heritable disorders of the connective tissue
Arun C Inamadar, Aparna Palit
July-August 2004, 70(4):253-255
PMID:17642631
  21,496 510 2
CASE REPORT
Squamous cell carcinoma of the scalp arising from chronic cutaneous lupus erythematosus: Report of two Indian patients
Bikash Ranjan Kar, Vinod Nair, Gigi Ebenezer, CK Job
July-August 2004, 70(4):236-238
PMID:17642623
Squamous cell carcinoma (SCC) usually arises in skin damaged by actinic rays. Exposure to chemicals like coal tar, soot, arsenic and a variety of oils and distillation products is also implicated in its pathogenesis. It occasionally occurs in scars following inflammatory or degenerative processes. It is an end stage complication of a wide array of inflammatory skin conditions. SCC complicating chronic cutaneous lupus erythematosus (CCLE) in Indian patients is rarely reported. Here we report two such Indian patients with long standing CCLE in whom the diagnosis of CCLE and SCC was confirmed by histopathology.
  10,632 162 1
Nodular fasciitis
MJ Cyriac, MI Celine, George Kurien, Usha Puthiode
July-August 2004, 70(4):239-241
PMID:17642624
A 24-year-old female presented with a firm, hyperpigmented, and gradually enlarging, tender, solitary dermal nodule of non-traumatic origin over the right suprascapular region. The lesion was extending into the subcutaneous tissue. She was otherwise normal. There was no calcification on X-ray. Biopsy revealed numerous large pleomorphic fibroblasts in a mucoid ground substance diagnostic of nodular fasciitis. No recurrence was noticed after surgical excision. This case is reported because of its rarity in the Indian medical literature.
  10,273 207 1
STUDIES
Skin changes in internal malignancy
Ravi Rajagopal, PN Arora, CV Ramasastry, PK Kar
July-August 2004, 70(4):221-225
PMID:17642619
BACKGROUND: Internal malignancies are accompanied by various skin changes which may be specific infiltrates or non-specific changes. This study is aimed at determining the frequency of such changes in malignant disease treatment center attendees in India. METHODS: A study of 300 confirmed cases of internal malignancy at a malignant disease treatment center was undertaken to evaluate these skin changes. Specific infiltrates were confirmed by histopathology. Statistical methods were employed to calculate significance in non-specific lesions by comparing with 300 controls not suffering from internal malignancy. RESULTS: Skin changes were present in 82 (27.3%). Cutaneous metastases were found in 19 (6.3%); non-contiguous in 5 (1.6%); contiguous in 14 (4.3%). Non-specific skin lesions numbered 74 (11.6%) in 52 patients. Statistically significant non-specific skin changes were acquired ichthyosis, herpes zoster and generalized pruritus. CONCLUSION: Metastases usually occurred late in internal malignancy (17, 5.6%) except in a case each of histiocytic lymphoma and non-Hodgkin's lymphoma (2, 0.7%) where the lesions preceded malignancy by 3 months and 1 month respectively. Contiguous nodules were a marker of relapse after surgery in 3 (1%).
  8,005 353 1
LETTER TO EDITOR
ANA-negative systemic lupus erythematosus
D VS Pratap, Sivarami K Reddy, Sudha C Rani, Venkata A Krishna, D Indira
July-August 2004, 70(4):243-244
PMID:17642626
  7,977 247 -
STUDIES
Half an hour versus three hour contact of topical steroid (clobetasol propionate)
Reena Rai, Monica Uppal, Narashima K Sharma, CR Srinivas, Anil Mathew
July-August 2004, 70(4):214-216
PMID:17642617
BACKGROUND: Steroids when left on the skin for longer duration may contribute to the side effects without any additional clinical benefit. The relationship between the duration of topical steroid contact with the skin and its effectiveness has not been established. The ability of the topical steroids to inhibit the size of histamine induced wheal was used to assess their relative efficacy. AIM: To determine whether half an hour contact and three hour contact of a topical steroid, clobetasol propionate, is equally effective in inhibiting the size of the histamine induced wheal. METHODS: On 30 volunteers, 4 squares were marked on flexor aspect of both forearms using a template. One fingertip unit of clobetasol propionate 0.05% was applied on all the areas. Half an hour later all areas of left forearm and last square of right forearm were wiped. Prick testing was done with histamine and size of wheal recorded after 15 minutes. Similarly steroid was wiped from the 1st, 2nd, 3rd square after 1 hr, 2 hr and 3 hrs on right forearm and the corresponding areas prick tested on both forearms. RESULTS: There was statistically significant wheal suppression at the end of 2 hrs and 3hrs as compared to half an hour. CONCLUSION: We conclude that half an hour application of clobetasol propionate is ineffective and that it is effective only after two hours of contact and hence short contact of half an hour will be less effective than relatively prolonged contact of 2 hours.
  7,752 170 2
Study of sexual behavior in male soldiers for STD/HIV prevention opportunities
NS Walia, CS Tak
July-August 2004, 70(4):226-229
PMID:17642620
BACKGROUND: A survey was undertaken in patients of sexually transmitted infections with the aim of exploring STD and HIV prevention opportunities. METHODS: A behavioral survey was conducted on 56 soldiers while being treated or followed up for a sexually transmitted disease. They were studied for their attitude and sexual activity patterns relevant to the transmission of STDs. In addition, the individual's outlook to sexual life and motivation factors was assessed. RESULTS: The study revealed that the source of infection of STD was equally divided between commercial sex worker (CSW) and casual sexual relationships. The majority did not use barrier contraceptives and knowledge about their protective role was insufficient. Access to health education was satisfactory; however, awareness levels for preventive action were still inadequate. Homosexuality was rare and most soldiers could stay without frequent sex. Alcohol was not found to be a significant co-factor. CONCLUSIONS: Heterosexual contact remains the main route of sexual contact. A wide variation in casual relationships and motivating factors was noted. Long abstinence and transit periods, traditionally considered major reasons for a soldier's indulgence in sex did not seem to play a major role. The role of sex parlors in the army was negated.
  7,655 172 -
In-vitro lymphocyte toxicity to a phenytoin metabolite in phenytoin induced cutaneous adverse drug eruptions
Ravishankar Dwivedi, Nithya Gogtay, Vidya Kharkar, Sangeeta Amladi, Nilima Kshirsagar
July-August 2004, 70(4):217-220
PMID:17642618
BACKGROUND: Phenytoin, one of the most commonly used antiepileptic drug, is associated with a wide spectrum of adverse drug eruptions. It is metabolized by the hepatic microsomal enzymes. The intermediate metabolites are arene oxides which accumulate due to deficiency of the enzyme epoxide hydrolase. These are postulated to be associated with phenytoin induced hepatotoxicity and antiepileptic hypersensitivity syndrome. AIM: We tried to correlate the in vitro lymphocyte toxicity of arene oxide metabolites with phenytoin induced drug eruptions and hence develop it as a predictive test for the same. METHODS: Clinically diagnosed cases of phenytoin induced drug eruptions were selected in this hospital based study. Lymphocytes from the subjects and controls were exposed to the phenytoin metabolites generated by a murine hepatic microsomal system. The toxicity was assayed by trypan blue dye exclusion test. The results were analyzed by a linear orthogonal curve and were compared for the subject and control. RESULTS: The results showed increased toxicity to lymphocytes from the patients when compared to those from controls. The toxicity was directly proportional to the severity of the drug eruption. CONCLUSION: In vitro lymphocyte cytotoxicity to phenytoin metabolites tested in this animal system could possibly predict phenytoin induced drug eruptions.
  7,006 232 3
CASE REPORT
Diffuse plane normolipemic xanthomatosis associated with Takayasu's disease and hyperhomocysteinemia: A case report
Giampiero Fichera, Eduardo Anastasio, Fabrizio Capasso, Maria D'Avino, Annamaria Margarita, Domenico Caruso
July-August 2004, 70(4):230-233
PMID:17642621
We describe a case of diffuse plane normolipemic xanthomatosis (DPNX) associated with Takayasu's disease and hyperhomocysteinemia. This report of an association of Takayasu's disease with hyperhomocysteinemia and DPNX is the only such report in literature. This report corroborates the study by Marcoval et al on 8 patients in 1988 where they highlighted that in every case of DPNX a possible concomitant condition should be always suspected and found out.
  6,610 129 -
LETTER TO EDITOR
Dexamethasone cyclophosphamide pulse therapy for pemphigus
Navin Modi
July-August 2004, 70(4):244-246
PMID:17642627
  6,404 236 -
CASE REPORT
Lichen planus secondary to hepatitis B vaccination
Akhilesh Agrawal, Shrutakirti D Shenoi
July-August 2004, 70(4):234-235
PMID:17642622
The association of lichen planus (LP) with liver diseases is now well established. Recent reports suggest that the hepatitis viruses may play a central role in this association. Lichen planus following hepatitis B vaccination is much more unusual. A 19-year-old previously healthy male developed itchy violaceous papules and plaques over the upper extremities eight to ten days after the first injection of hepatitis B vaccine. He developed similar lesions over the upper trunk, neck and lower leg after the second and third injections. A skin biopsy showed a lichenoid tissue reaction. Direct immunofluorescence (DIF) showed multiple colloid bodies and a strong continuous ragged basement membrane zone (BMZ) band with fibrinogen. HbsAg by ELISA and anti-HCV antibodies were negative. The patient was treated with oral steroids and the lesions improved. LP is a pruritic inflammatory dermatosis of unknown origin. An increased prevalence of liver disease in patient with LP has been reported. Since the first case reported by Rebora in 1990, about 15 cases of LP occurring after hepatitis B vaccination have been reported in the literature irrespective of the type of vaccine used.
  6,416 186 5
LETTER TO EDITOR
Response by Dr. Pasricha
JS Pasricha
July-August 2004, 70(4):249-250
  6,436 138 -
MEDICOLEGAL WINDOW
Claims of cosmetic products
Subodh Sirur
July-August 2004, 70(4):251-252
PMID:17642630
  6,085 144 -
LETTER TO EDITOR
Dexamethasone cyclophosphamide pulse therapy: Some suggestions for modifications
Vijay Gandhi, SN Bhattacharya
July-August 2004, 70(4):246-247
PMID:17642628
  5,644 199 -
Colocalisation of alopecia areata and lichen planus
Bikash Ranjan Kar, Gigi Ebenezer, CK Job
July-August 2004, 70(4):242-243
PMID:17642625
  5,610 143 1
QUIZ
Sclerodermoid hands with waxy papules on face
MK Singhi, Lalit K Gupta, Dilip Kachhawa, Mohit Bansal, Dhruv Gupta
July-August 2004, 70(4):263-265
PMID:17642634
  5,398 112 -
STUDIES
Failure of titer of contact hypersensitivity to correlate with clinical severity and therapeutic response in contact dermatitis caused by parthenium
Kaushal K Verma, Yashpal Manchanda, SN Dwivedi
July-August 2004, 70(4):210-213
PMID:17642616
Background: The titer of contact hypersensitivity (TCH) has been used to determine the degree of contact hypersensitivity in patients with contact dermatitis. The values have been found to vary in different individuals and also in the same individual at different times apparently due to the varying severity of the disease. We evaluated the correlation of TCH with disease severity and therapeutic response in patients of contact dermatitis caused by the plant Parthenium hysterophorus. Methods: Forty-two patients, 30 (71.4%) males and 12 (28.6%) females, aged between 30-75 years, having air-borne contact dermatitis to Parthenium hysterophorus for 0.5-20 years were included in the study. The disease severity and TCH at baseline were recorded in all the patients. They were treated with azathioprine and followed up every month for 4-69 months. The TCH was repeated every 3 months and the last recorded TCH value was taken for analysis in each patient. Results: The baseline clinical severity score (CSS) varied from 10-80 (mean ± SD: 35.47 ± 19.41) in these patients. It ranged from 10-30 in 22 (52.4%) patients, from 31-50 in 14 (33.3%) patients, and was more than 50 in 6 (14.3%) patients. The baseline TCH to Parthenium was undiluted (UD) in 2 (4.8%), 1:10 in 15 (35.7%), 1:100 in 20 (47.6%), and 1:1000 in 5 (11.9%) patients respectively. At the end of the study, the clinical severity of the disease decreased in most of the patients. The CSS came down to 0 in 31 patients, to 10-20, and to 50 in 4 patients each, but remained stable in three patients who had baseline CSS from 20-40. The overall mean CSS came down from 35.47 ± 19.41 to 4.76 ± 9.43 (p = 0.002). However, there was no significant change in the TCH levels over time (p = 0.153). The last TCH value was negative in 2 (4.8%) patients, undiluted in 5 (11.9%), 1:10 in 10 (23.8%), 1:100 in 18 (42.9%), and 1:1000 in 7 (16.7%) patients. There was no change in the TCH values in 16 (38.1%) patients while it increased or decreased by 1-2 dilutions in 12 (28.6%) patients each. Conclusions: We therefore conclude that the TCH does not correlate with the clinical severity of contact dermatitis or response to treatment.
  5,259 117 2
PRESIDENTIAL ADDRESS
Presidential address at the 32nd National Conference of IADVL, January 2004, Mumbai
RJ Fernandez
July-August 2004, 70(4):203-204
PMID:17642614
  4,889 66 1
LETTER TO EDITOR
Response by Dr. Ramam
M Ramam
July-August 2004, 70(4):248-249
  4,542 93 -
Response by Dr. Rao and Dr. Laxmi
P Narasimha Rao, T SS Laxmi
July-August 2004, 70(4):247-248
  4,440 84 -
Rheumatological manifestations of leprosy
Kumar Sudhir
July-August 2004, 70(4):250-250
PMID:17642629
  3,732 107 -
BOOK REVIEW
Current literature dermatology 2002-2003
AK Bajaj
July-August 2004, 70(4):262-262
  3,645 79 -
Online since 15th March '04
Published by Wolters Kluwer - Medknow